Document Detail


Is there a correlation between serum antifungal drug concentration and clinical outcome?
MedLine Citation:
PMID:  8077687     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Effective broad spectrum antifungal therapy has been available since the introduction of amphotericin B three decades ago. Amphotericin B must be given intravenously, and thus access to the bloodstream is assured. Because of the great toxicity of this agent, initial studies were directed at determining a dose which was tolerable and clinically effective. In part because of few data and in part because of major concerns with toxicity, there is at present no established relationship with amphotericin B serum concentrations and clinical outcome, and there is no clear indication for measurement of serum concentrations of this drug. More recently there has appeared a variety of orally administered antifungal azole derivatives. Oral absorption is affected by a variety of factors, and drug access to the blood stream is not readily predictable for some of these drugs. Serum concentrations have not been consistently assessed in clinical studies. Where they have been measured, there does appear to be a loose correlation of clinical response with the detection of some amount of drug in the bloodstream. However, beyond this 'threshold' concentration, there is no compelling evidence for a correlation of serum concentration and clinical outcome. While serum concentration of azoles may be useful in determining absorption of drug, at present there is no impetus for achieving a given concentration in the blood to improve chances of a good outcome.
Authors:
J R Graybill
Related Documents :
15357417 - Gentamicin pharmacokinetics in the chicken inner ear.
103187 - Myelomatosis after phenytoin therapy: a chance association?
8251617 - Influence of albumin on isoprenaline and propranolol effects on isolated rat uterus.
2213857 - Increased carbon monoxide excretion in bolivian squirrel monkeys with fasting hyperbili...
14679477 - Mycobacterium tuberculosis: the treatment of active disease.
15004447 - Criminality in drug addicts: a follow-up study over 25 years.
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  The Journal of infection     Volume:  28 Suppl 1     ISSN:  0163-4453     ISO Abbreviation:  J. Infect.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-10-06     Completed Date:  1994-10-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7908424     Medline TA:  J Infect     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  17-24     Citation Subset:  IM    
Affiliation:
Veterans Administration Hospital, San Antonio, TX 78284.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Amphotericin B / administration & dosage,  adverse effects,  blood,  pharmacokinetics
Antifungal Agents / blood*
Humans
Injections, Intravenous
Itraconazole / pharmacokinetics
Ketoconazole / pharmacokinetics
Liver / metabolism
Microbial Sensitivity Tests
Mycoses / blood,  drug therapy*
Piperazines / pharmacokinetics
Risk Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antifungal Agents; 0/Piperazines; 1397-89-3/Amphotericin B; 65277-42-1/Ketoconazole; 84625-61-6/Itraconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mucormycosis (zygomycosis): is there news for the clinician?
Next Document:  Treatment of invasive aspergillosis.